TYRA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.40%

Insider Buying (Last 12 Months): $152,000.00

Insider Selling (Last 12 Months): $2,654,349.44

Tyra Biosciences Insider Trading History Chart

Tyra Biosciences Share Price & Price History

^$10.74

▼ -0.08 (-0.74%)

As of 03/13/2025 05:00 PM ET

Days: 30 | 90 | 365

Tyra Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/5/2025	Nina S Kjellson	Director	Sell	5,401	$13.76	$74,317.76	443,885
1/23/2025	Nina S Kjellson	Director	Sell	4,825	$16.26	$78,454.50	3,702,595
1/21/2025	Nina S Kjellson	Director	Sell	3,993	$16.36	$65,325.48	3,707,420
1/16/2025	Nina S Kjellson	Director	Sell	7,779	$16.29	$126,719.91	447,857
11/4/2024	Nina S Kjellson	Director	Sell	1,076	$17.01	$18,302.76	458,390
11/1/2024	Nina S Kjellson	Director	Sell	27,493	$16.56	$455,284.08	458,506
10/30/2024	Alan Fuhrman	CFO	Buy	9,500	$16.00	$152,000.00	12,849
10/30/2024	Nina S Kjellson	Director	Sell	11,078	$16.17	$179,131.26	472,207
10/21/2024	Todd Harris	CEO	Sell	19,084	$27.90	$532,443.60	1,355,927
10/17/2024	Todd Harris	CEO	Sell	15,394	$25.85	$397,934.90	1,418,647
10/15/2024	Todd Harris	CEO	Sell	10,035	$24.31	$243,950.85	1,467,338
9/30/2024	Todd Harris	CEO	Sell	500	$24.00	$12,000.00	1,477,373
9/25/2024	Todd Harris	CEO	Sell	600	$24.01	$14,406.00	1,477,873
9/23/2024	Todd Harris	CEO	Sell	10,092	$24.13	$243,519.96	1,479,528
9/19/2024	Todd Harris	CEO	Sell	5,698	$24.31	$138,518.38	1,496,729
6/10/2024	Daniel Bensen	COO	Sell	3,502	$20.00	$70,040.00	427,981
6/7/2024	Daniel Bensen	COO	Sell	200	$20.00	$4,000.00	431,483
3/11/2024	Daniel Bensen	COO	Sell	200	$20.00	$4,000.00	431,683
3/6/2024	Daniel Bensen	COO	Sell	1,733	$20.09	$34,815.97	431,951
2/29/2024	Daniel Bensen	COO	Sell	2,050	$20.00	$41,000.00	442,836
2/27/2024	Daniel Bensen	COO	Sell	745	$20.00	$14,900.00	450,735
2/12/2024	Daniel Bensen	COO	Sell	1,501	$20.00	$30,020.00	451,480
2/7/2024	Daniel Bensen	COO	Sell	9,587	$18.09	$173,428.83	452,981
7/21/2023	Daniel Bensen	COO	Sell	3,900	$16.01	$62,439.00	527,981
7/19/2023	Daniel Bensen	COO	Sell	207	$16.07	$3,326.49	527,981
7/17/2023	Daniel Bensen	COO	Sell	1,900	$16.03	$30,457.00	527,981
7/13/2023	Daniel Bensen	COO	Sell	500	$16.13	$8,065.00	527,981
7/11/2023	Daniel Bensen	COO	Sell	500	$16.02	$8,010.00	527,981
7/3/2023	Daniel Bensen	COO	Sell	4,265	$16.37	$69,818.05	527,981
6/30/2023	Daniel Bensen	COO	Sell	18,819	$16.97	$319,358.43	527,981
6/27/2023	Daniel Bensen	COO	Sell	16,028	$16.91	$271,033.48	527,981
6/22/2023	Todd Harris	CEO	Sell	3,478	$17.04	$59,265.12	1,621,988
6/20/2023	Todd Harris	CEO	Sell	1,300	$16.53	$21,489.00	1,645,222
6/15/2023	Todd Harris	CEO	Sell	12,773	$16.13	$206,028.49	1,701,276
6/14/2023	Daniel Bensen	COO	Sell	120	$16.45	$1,974.00	527,981
6/13/2023	Todd Harris	CEO	Sell	7,927	$16.00	$126,832.00	1,701,276
4/3/2023	Daniel Bensen	COO	Sell	2,000	$16.16	$32,320.00	527,981
3/31/2023	Daniel Bensen	COO	Sell	400	$16.00	$6,400.00	527,981
3/30/2023	Todd Harris	CEO	Sell	2,407	$16.02	$38,560.14	1,701,276
3/29/2023	Daniel Bensen	COO	Sell	2,187	$16.21	$35,451.27	527,981
3/28/2023	Todd Harris	CEO	Sell	2,779	$16.00	$44,464.00	1,701,276
3/27/2023	Daniel Bensen	COO	Sell	8,048	$16.00	$128,768.00	527,981
3/24/2023	Todd Harris	CEO	Sell	170	$16.00	$2,720.00	1,701,276
3/22/2023	Daniel Bensen	COO	Sell	3,800	$16.00	$60,800.00	527,981
3/22/2023	Todd Harris	CEO	Sell	4,043	$16.00	$64,688.00	1,701,276
2/9/2023	Mva Investors, Llc	Major Shareholder	Sell	200,000	$13.10	$2,620,000.00	88,095

See Full Table

SEC Filings (Institutional Ownership Changes) for Tyra Biosciences (NASDAQ:TYRA)

84.14% of Tyra Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Tyra Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/25/2025	Polar Asset Management Partners Inc.	111,107	$1.54M	0.0%	+26.1%	0.220%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	35,635	$0.50M	0.0%	+41.4%	0.070%
2/17/2025	Vestal Point Capital LP	990,000	$13.76M	0.8%	N/A	1.956%
2/17/2025	Squarepoint Ops LLC	18,216	$0.25M	0.0%	N/A	0.036%
2/17/2025	Two Sigma Advisers LP	12,300	$0.17M	0.0%	N/A	0.024%
2/17/2025	Two Sigma Investments LP	46,269	$0.64M	0.0%	+18.1%	0.091%
2/17/2025	Point72 Asset Management L.P.	12,783	$0.18M	0.0%	N/A	0.025%
2/17/2025	Polar Asset Management Partners Inc.	111,107	$1.54M	0.0%	+26.1%	0.220%
2/17/2025	Orbimed Advisors LLC	1,470,086	$20.43M	0.4%	+91.3%	2.905%
2/17/2025	Millennium Management LLC	315,141	$4.38M	0.0%	+2,900.2%	0.623%
2/17/2025	Jacobs Levy Equity Management Inc.	244,245	$3.40M	0.0%	N/A	0.483%
2/17/2025	Janus Henderson Group PLC	1,746,320	$24.29M	0.0%	+63.6%	3.451%
2/17/2025	Farallon Capital Management LLC	1,000,981	$13.91M	0.1%	N/A	1.978%
2/17/2025	Deutsche Bank AG	18,909	$0.26M	0.0%	+52.0%	0.037%
2/17/2025	Cubist Systematic Strategies LLC	109,748	$1.53M	0.0%	N/A	0.217%
2/17/2025	BVF Inc. IL	3,944,194	$54.82M	1.9%	-15.4%	7.795%
2/17/2025	Bank of America Corp DE	66,157	$0.92M	0.0%	+21.7%	0.131%
2/17/2025	BNP Paribas Financial Markets	4,318	$60K	0.0%	N/A	0.009%
2/17/2025	Ally Bridge Group NY LLC	175,063	$2.43M	2.0%	-35.2%	0.346%
2/14/2025	Boxer Capital Management LLC	2,027,678	$28.19M	2.4%	N/A	4.007%
2/14/2025	RA Capital Management L.P.	10,637,290	$147.86M	1.9%	+2.1%	21.022%
2/14/2025	PDT Partners LLC	20,359	$0.28M	0.0%	N/A	0.040%
2/14/2025	Nantahala Capital Management LLC	100,000	$1.39M	0.1%	N/A	0.198%
2/14/2025	Northern Trust Corp	222,764	$3.10M	0.0%	+3.9%	0.440%
2/14/2025	The Manufacturers Life Insurance Company	13,368	$0.19M	0.0%	-5.8%	0.026%
2/14/2025	Tudor Investment Corp ET AL	15,577	$0.22M	0.0%	-40.9%	0.031%
2/14/2025	Aquatic Capital Management LLC	4,586	$64K	0.0%	N/A	0.009%
2/14/2025	Boothbay Fund Management LLC	17,560	$0.24M	0.0%	N/A	0.035%
2/14/2025	Susquehanna Fundamental Investments LLC	39,093	$0.54M	0.0%	N/A	0.077%
2/14/2025	Dimensional Fund Advisors LP	37,981	$0.53M	0.0%	+283.4%	0.075%
2/13/2025	Marshall Wace LLP	54,077	$0.75M	0.0%	+175.7%	0.107%
2/13/2025	Jump Financial LLC	15,160	$0.21M	0.0%	N/A	0.030%
2/13/2025	Walleye Capital LLC	62,980	$0.88M	0.0%	-50.3%	0.124%
2/13/2025	Investment Counsel Co. of Nevada	85,020	$1.18M	3.0%	N/A	0.168%
2/13/2025	Barclays PLC	43,070	$0.60M	0.0%	+14.5%	0.085%
2/13/2025	Raymond James Financial Inc.	54,783	$0.76M	0.0%	N/A	0.108%
2/13/2025	Renaissance Technologies LLC	29,100	$0.40M	0.0%	N/A	0.058%
2/13/2025	Russell Investments Group Ltd.	10,455	$0.15M	0.0%	+130,587.5%	0.021%
2/13/2025	Wells Fargo & Company MN	9,493	$0.13M	0.0%	+51.7%	0.019%
2/12/2025	Geode Capital Management LLC	517,578	$7.20M	0.0%	-1.1%	1.023%
2/12/2025	Wellington Management Group LLP	94,859	$1.32M	0.0%	+4.4%	0.187%
2/12/2025	Pictet Asset Management Holding SA	354,012	$4.92M	0.0%	N/A	0.700%
2/12/2025	JPMorgan Chase & Co.	91,115	$1.27M	0.0%	-75.3%	0.180%
2/11/2025	EntryPoint Capital LLC	18,209	$0.25M	0.1%	N/A	0.036%
2/11/2025	Vanguard Group Inc.	1,207,765	$16.79M	0.0%	-3.0%	2.387%
2/11/2025	KLP Kapitalforvaltning AS	2,200	$31K	0.0%	N/A	0.004%
2/11/2025	American Century Companies Inc.	22,142	$0.31M	0.0%	-48.5%	0.044%
2/10/2025	Swiss National Bank	20,700	$0.29M	0.0%	-19.5%	0.041%
2/7/2025	AlphaQuest LLC	5,023	$70K	0.0%	-75.9%	0.010%
2/6/2025	Raymond James Financial Inc.	54,783	$0.76M	0.0%	N/A	0.108%
2/6/2025	Victory Capital Management Inc.	56,640	$0.79M	0.0%	+88.3%	0.112%
2/6/2025	Charles Schwab Investment Management Inc.	170,600	$2.37M	0.0%	-1.8%	0.337%
2/5/2025	Alta Partners Management Company L.P.	4,080,296	$56.72M	89.5%	N/A	8.064%
2/5/2025	US Bancorp DE	3,612	$50K	0.0%	N/A	0.007%
2/5/2025	Oppenheimer & Co. Inc.	75,439	$1.05M	0.0%	-1.8%	0.149%
2/4/2025	Bank of New York Mellon Corp	45,007	$0.63M	0.0%	+5.2%	0.089%
1/30/2025	Rhumbline Advisers	26,202	$0.36M	0.0%	+4.1%	0.052%
1/24/2025	China Universal Asset Management Co. Ltd.	10,730	$0.15M	0.0%	N/A	0.021%
1/21/2025	Canaan Partners XI LLC	4,179,857	$58.10M	75.2%	-5.2%	8.261%
1/17/2025	SG Americas Securities LLC	9,671	$0.13M	0.0%	-26.8%	0.019%
12/26/2024	JPMorgan Chase & Co.	368,647	$8.67M	0.0%	+1.1%	0.729%
11/27/2024	Franklin Resources Inc.	12,647	$0.28M	0.0%	N/A	0.025%
11/19/2024	Barclays PLC	37,625	$0.88M	0.0%	+200.5%	0.074%
11/15/2024	Frazier Life Sciences Management L.P.	731,020	$17.19M	0.7%	-12.2%	1.445%
11/15/2024	Barclays PLC	37,625	$0.88M	0.0%	+200.5%	0.074%
11/15/2024	Wellington Management Group LLP	90,825	$2.14M	0.0%	-22.4%	0.179%
11/15/2024	State Street Corp	384,732	$9.05M	0.0%	+4.4%	0.760%
11/15/2024	Polar Asset Management Partners Inc.	88,100	$2.07M	0.0%	N/A	0.174%
11/15/2024	Janus Henderson Group PLC	1,067,196	$24.99M	0.0%	N/A	2.109%
11/15/2024	Cinctive Capital Management LP	22,900	$0.54M	0.0%	N/A	0.045%
11/14/2024	Sio Capital Management LLC	400,870	$9.42M	3.7%	-33.2%	0.792%
11/14/2024	Walleye Capital LLC	126,597	$2.98M	0.0%	+306.5%	0.250%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	25,209	$0.59M	0.0%	N/A	0.050%
11/14/2024	Ally Bridge Group NY LLC	270,075	$6.35M	3.4%	+2.0%	0.534%
11/13/2024	FMR LLC	3,372,850	$79.30M	0.0%	+0.8%	6.666%
11/13/2024	The Manufacturers Life Insurance Company	14,184	$0.33M	0.0%	N/A	0.028%
11/12/2024	Valence8 US LP	13,188	$0.31M	0.1%	N/A	0.025%
11/12/2024	Charles Schwab Investment Management Inc.	173,737	$4.09M	0.0%	+2.2%	0.329%
11/8/2024	Jennison Associates LLC	158,187	$3.72M	0.0%	+5.9%	0.300%
11/7/2024	Quest Partners LLC	20,878	$0.49M	0.0%	N/A	0.040%
11/6/2024	Oppenheimer & Co. Inc.	76,806	$1.81M	0.0%	+9.0%	0.145%
11/5/2024	Victory Capital Management Inc.	30,080	$0.71M	0.0%	-36.2%	0.057%
10/30/2024	Auour Investments LLC	21,020	$0.49M	0.2%	-75.3%	0.040%
10/10/2024	Exchange Traded Concepts LLC	8,311	$0.20M	0.0%	-32.1%	0.016%
10/3/2024	SG Americas Securities LLC	13,211	$0.31M	0.0%	N/A	0.025%
8/16/2024	Perceptive Advisors LLC	1,007,367	$16.11M	0.4%	+50.5%	1.908%
8/14/2024	Ally Bridge Group NY LLC	264,660	$4.23M	2.5%	N/A	0.501%
8/14/2024	HighVista Strategies LLC	16,078	$0.26M	0.1%	N/A	0.030%
8/13/2024	Ensign Peak Advisors Inc	190,557	$3.05M	0.0%	N/A	0.361%
8/8/2024	American Century Companies Inc.	170,283	$2.72M	0.0%	+582.9%	0.324%
8/5/2024	Victory Capital Management Inc.	47,160	$0.75M	0.0%	-1.9%	0.090%
8/1/2024	Rhumbline Advisers	23,572	$0.38M	0.0%	+12.3%	0.045%
7/26/2024	Bank of New York Mellon Corp	58,087	$0.93M	0.0%	+32.8%	0.111%
5/17/2024	RA Capital Management L.P.	10,416,609	$170.83M	2.2%	+43.9%	19.826%
5/16/2024	Kynam Capital Management LP	515,190	$8.45M	0.9%	+51.4%	0.981%
5/16/2024	BVF Inc. IL	4,661,194	$76.44M	2.1%	+70.1%	8.872%
5/10/2024	Vanguard Group Inc.	899,800	$14.76M	0.0%	+18.6%	1.713%
5/7/2024	Oppenheimer & Co. Inc.	59,576	$0.98M	0.0%	N/A	0.113%
4/23/2024	Fishman Jay A Ltd. MI	15,000	$0.25M	0.0%	N/A	0.029%
3/5/2024	Wellington Management Group LLP	102,436	$1.42M	0.0%	+8.8%	0.238%

Data available starting January 2016

See Full Table

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

Today's Range

Now: $10.74

$10.53

$11.12

50 Day Range

MA: $13.70

$10.16

$16.73

52 Week Range

Now: $10.74

$9.93

$29.60

Volume

266,847 shs

Average Volume

281,955 shs

Market Capitalization

$543.48 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Who are the company insiders with the largest holdings of Tyra Biosciences?: Tyra Biosciences' top insider investors include:
Nina S Kjellson (Director)
Todd Harris (CEO)
Daniel Bensen (COO)
Alan Fuhrman (CFO)
Learn More about top insider investors at Tyra Biosciences.
Who are the major institutional investors of Tyra Biosciences?: Tyra Biosciences' top institutional investors include:
RA Capital Management L.P. — 21.02%
Canaan Partners XI LLC — 8.26%
Alta Partners Management Company L.P. — 8.06%
BVF Inc. IL — 7.79%
Boxer Capital Management LLC — 4.01%
Janus Henderson Group PLC — 3.45%
Learn More about top institutional investors of Tyra Biosciences stock.
Which institutional investors are selling Tyra Biosciences stock?: Within the last quarter, TYRA stock was sold by these institutional investors:
BVF Inc. IL
JPMorgan Chase & Co.
Canaan Partners XI LLC
Ally Bridge Group NY LLC
Walleye Capital LLC
Vanguard Group Inc.
American Century Companies Inc.
AlphaQuest LLC
In the last year, company insiders that have sold Tyra Biosciences company stock include:
Nina S Kjellson (Director)
Todd Harris (CEO)
Daniel Bensen (COO)
Learn More investors selling Tyra Biosciences stock.
Which institutional investors are buying Tyra Biosciences stock?: In the last quarter, TYRA stock was purchased by institutional investors including:
Alta Partners Management Company L.P.
Boxer Capital Management LLC
Farallon Capital Management LLC
Vestal Point Capital LP
Orbimed Advisors LLC
Janus Henderson Group PLC
Pictet Asset Management Holding SA
Millennium Management LLC